Inhibition of platelet activation by peptide analogs of the β₃-intracellular domain of platelet integrin α_IIbβ₃ conjugated to the cell-penetrating peptide Tat(48–60)

References

• Hynes RO. Integrins: A family of cell surface receptors. Cell 1987; 48: 549–554
   PubMed Web of Science ®Google Scholar
• Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11–25
   PubMed Web of Science ®Google Scholar
• Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: The platelet paradigm. Blood 1998; 91: 2645–2657
   PubMed Web of Science ®Google Scholar
• Litjens PE, Akkerman JW, van Willigen G. Platelet integrin alphaIIbbeta3: Target and generator of signalling. Platelets 2000; 11: 310–319
   PubMedGoogle Scholar
• Dedhar S, Hannigan GE. Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr Opin Cell Biol 1996; 8: 657–669
   PubMed Web of Science ®Google Scholar
• Shattil SJ. Signaling through platelet integrin alpha IIb beta 3: Inside-out, outside-in, and sideways. Thromb Haemost 1999; 82: 318–325
   PubMed Web of Science ®Google Scholar
• Biris N, Abatzis M, Mitsios JV, Sakarellos-Daitsiotis M, Sakarellos C, Tsoukatos D, Tselepis AD, Michalis L, Sideris D, Konidou G, et al. Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3). Eur J Biochem 2003; 270: 3760–3767
   PubMedGoogle Scholar
• Mitsios JV, Tambaki AP, Abatzis M, Biris N, Sakarellos-Daitsiotis M, Sakarellos C, Soteriadou K, Goudevenos J, Elisaf M, Tsoukatos D, et al. Effect of synthetic peptides corresponding to residues 313–332 of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3. Eur J Biochem 2004; 271: 855–862
   PubMedGoogle Scholar
• Mitsios JV, Stamos G, Rodis FI, Tsironis LD, Stanica MR, Sakarellos C, Tsoukatos D, Tsikaris V, Tselepis AD. Investigation of the role of adjacent amino acids to the 313–320 sequence of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3. Platelets 2006; 17: 277–282
   PubMed Web of Science ®Google Scholar
• Stanica R, Benaki D, Rodis FI, Mikros E, Tsoukatos D, Tselepis A, Tsikaris V. Structure–activity relationships of alphaIIb 313–320 derived peptide inhibitors of human platelet aggregation. J Pept Sci 2008; 14: 1195–1202
   PubMedGoogle Scholar
• Tsikaris V. The anti-platelet approach targeting the fibrinogen ligand of the GPIIB/IIIa receptor. J Pept Sci 2004; 10: 589–602
   PubMed Web of Science ®Google Scholar
• Vinogradova O, Velyvis A, Velyviene A, Hu B, Haas T, Plow E, Qin J. A structural mechanism of integrin alpha(IIb)beta(3) “inside-out” activation as regulated by its cytoplasmic face. Cell 2002; 110: 587–597
   PubMed Web of Science ®Google Scholar
• Koloka V, Christofidou ED, Vaxevanelis S, Dimitriou AA, Tsikaris V, Tselepis AD, Panou-Pomonis E, Sakarellos-Daitsiotis M, Tsoukatos DC. A palmitoylated peptide, derived from the acidic carboxyl-terminal segment of the integrin alphaIIb cytoplasmic domain, inhibits platelet activation. Platelets 2008; 19: 502–511
   PubMed Web of Science ®Google Scholar
• Liu S, Calderwood DA, Ginsberg MH. Integrin cytoplasmic domain-binding proteins. J Cell Sci 2000; 113: 3563–3571
   PubMed Web of Science ®Google Scholar
• Zhao R, Pathak AS, Stouffer GA. beta(3)-Integrin cytoplasmic binding proteins. Arch Immunol Ther Exp (Warsz) 2004; 52: 348–355
   PubMedGoogle Scholar
• Xi X, Bodnar RJ, Li Z, Lam SC, Du X. Critical roles for the COOH-terminal NITY and RGT sequences of the integrin beta3 cytoplasmic domain in inside-out and outside-in signaling. J Cell Biol 2003; 162: 329–339
   PubMed Web of Science ®Google Scholar
• Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, Ginsberg MH. The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 1999; 274: 28071–28074
   PubMed Web of Science ®Google Scholar
• Calderwood DA, Yan B, de Pereda JM, Alvarez BG, Fujioka Y, Liddington RC, Ginsberg MH. The phosphotyrosine binding-like domain of talin activates integrins. J Biol Chem 2002; 277: 21749–21758
   PubMed Web of Science ®Google Scholar
• Eigenthaler M, Höfferer L, Shattil SJ, Ginsberg MH. A conserved sequence motif in the integrin beta3 cytoplasmic domain is required for its specific interaction with beta3-endonexin. J Biol Chem 1997; 272: 7693–7698
   PubMed Web of Science ®Google Scholar
• Kashiwagi H, Schwartz MA, Eigenthaler M, Davis KA, Ginsberg MH, Shattil SJ. Affinity modulation of platelet integrin alphaIIbbeta3 by beta3-endonexin, a selective binding partner of the beta3 integrin cytoplasmic tail. J Cell Biol 1997; 137: 1433–1443
   PubMed Web of Science ®Google Scholar
• Bodansky M, Bodansky A. The practice of peptide synthesis, 2nd. Springer, Berlin 1994
   Google Scholar
• Goodman M, Felix A, Moroder L, Toniolo G, ed. Methods of organic chemistry: Synthesis of peptide and peptidomimetics. Stuttgard: Thieme 2003
   Google Scholar
• Papas S, Akoumianaki T, Kalogiros C, Hadjiarapoglou L, Theodoropoulos PA, Tsikaris V. Synthesis and antitumor activity of peptide-paclitaxel conjugates. J Pept Sci 2007; 13: 662–671
   PubMedGoogle Scholar
• Tsironis LD, Mitsios JV, Milionis HJ, Elisaf M, Tselepis AD. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: Role of apolipoprotein (a) and endogenous PAF-acetylhydrolase. Cardiovasc Res 2004; 63: 130–138
   PubMed Web of Science ®Google Scholar
• Díaz-Ricart M, Arderiu G, Estebanell E, Pérez-Pujol S, Lozano M, White JG, Escolar G, Ordinas A. Inhibition of cytoskeletal assembly by cytochalasin B prevents signaling through tyrosine phosphorylation and secretion triggered by collagen but not by thrombin. Am J Pathol 2002; 160: 329–337
   PubMed Web of Science ®Google Scholar
• Vivès E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997; 272: 16010–16017
   PubMed Web of Science ®Google Scholar
• Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001; 276: 5836–5840
   PubMed Web of Science ®Google Scholar
• Futaki S, Goto S, Sugiura Y. Membrane permeability commonly shared among arginine-rich peptides. J Mol Recognit 2003; 16: 260–264
   PubMedGoogle Scholar
• Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 1996; 271: 18188–18193
   PubMed Web of Science ®Google Scholar
• Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003; 278: 585–590
   PubMed Web of Science ®Google Scholar
• Martin KMG, Moran N, Shields DC, Kenny D. A palmitylated peptide derived from the glycoprotein Ib beta cytoplasmic tail inhibits platelet activation. J Thromb Haemost 2003; 1: 2643–2652
   PubMed Web of Science ®Google Scholar
• Jie C, Ling Yu, Liping Wang, Xuexun Fang, Li Li, Wei Li. Stability of Synthetic Exendin-4 in Human Plasma In Vitro. Protein & Peptide Letters 2007; 14: 19–25
   PubMedGoogle Scholar
• Papamichael N, Stathopoulou EM, Roussa VD, Tsironis LD, Kotsia AP, Stanica RM, Moussis V, Tsikaris V, Katsouras CS, Tselepis AD, et al. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits. J Pharmacol Exp Ther 2009; 329: 634–640
   PubMed Web of Science ®Google Scholar
• Brinckerhoff L, Kalasnikov VV, Thompson LW, Yamshchikov GV, Pierce RA, Galavotti HS, Engelhard VH, Slinglff CL. Terminal modifications inhibit proteolytic degradation of an immunogenic MART-127-35 peptide: Implications for peptide vaccines. Int J Cancer 1999; 83: 326–334
   PubMed Web of Science ®Google Scholar
• Hers I, Donath J, Litjens PE, van Willigen G, Akkerman JW. Inhibition of platelet integrin alpha(IIb)beta(3) by peptides that interfere with protein kinases and the beta(3) tail. Arterioscler Thromb Vasc Biol 2000; 20: 1651–1660
   PubMedGoogle Scholar
• Liu KY, Timmons S, Lin YZ, Hawiger J. Identification of a functionally important sequence in the cytoplasmic tail of integrin beta 3 by using cell-permeable peptide analogs. Proc Natl Acad Sci USA 1996; 93: 11819–11824
   PubMed Web of Science ®Google Scholar
• Litjens PE, Kroner CI, Akkerman JW, Van Willigen G. Cytoplasmic regions of the beta3 subunit of integrin alphaIIbbeta3 involved in platelet adhesion on fibrinogen under flow conditions. J Thromb Haemost 2003; 1: 2014–2021
   PubMedGoogle Scholar